Sponsor or institution
Clinical trials and research at Il-Yang Pharm. Co., Ltd.
As of November 12, 2026, Find a Trial lists 2 clinical trials run by Il-Yang Pharm. Co., Ltd. that are recruiting, at sites in 4 countries (most in South Korea (2), Russia (1), Turkey (Türkiye) (1)). By phase: Phase 1 (1), Phase 3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 4Countries
All recruiting trials (2)
-
Safety, tolerability, and dosing of IY-828026 in healthy adults
This test tries to see how safe and well-tolerated IY-828026 is and how the body absorbs and clears it in healthy adults aged 19 to 50.
-
Efficacy and safety of Radotinib for chronic myeloid leukemia patients who failed previous treatments
This study is testing if Radotinib can help people with chronic myeloid leukemia who haven't had success with other treatments feel better and stay safe while using it.
Quick answers
How many clinical trials run by Il-Yang Pharm. Co., Ltd. are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 4 countries. The most sites are in South Korea (2 trials), Russia (1 trial), Turkey (Türkiye) (1 trial), Ukraine (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 1, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.